AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 216 filers reported holding AMICUS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $605,021 | -90.8% | 60,990 | -89.0% | 0.00% | -90.0% |
| Q1 2024 | $6,553,956 | +189.5% | 556,363 | +172.6% | 0.01% | 0.0% |
| Q1 2023 | $2,263,680 | +188.4% | 204,119 | +217.5% | 0.01% | +150.0% |
| Q4 2022 | $784,981 | +7.2% | 64,290 | -8.2% | 0.00% | 0.0% |
| Q3 2022 | $732,000 | +115.3% | 70,069 | +97.0% | 0.00% | 0.0% |
| Q3 2021 | $340,000 | +144.6% | 35,568 | +146.2% | 0.00% | +100.0% |
| Q2 2021 | $139,000 | -46.1% | 14,449 | -44.7% | 0.00% | -50.0% |
| Q1 2021 | $258,000 | -40.4% | 26,139 | -14.7% | 0.00% | -33.3% |
| Q3 2020 | $433,000 | +177.6% | 30,658 | +197.2% | 0.01% | +200.0% |
| Q2 2020 | $156,000 | – | 10,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 9,029,843 | $89,576,043 | 10.38% |
| Perceptive Advisors | 28,057,456 | $278,329,964 | 6.70% |
| Redmile Group, LLC | 10,595,089 | $105,103,283 | 6.36% |
| STEMPOINT CAPITAL LP | 1,495,047 | $14,830,866 | 4.36% |
| CM Management, LLC | 450,000 | $4,464,000 | 4.10% |
| Avoro Capital Advisors LLC | 27,400,000 | $271,808,000 | 3.62% |
| GREAT POINT PARTNERS LLC | 1,495,500 | $14,835,360 | 2.84% |
| Saturn V Capital Management LP | 713,536 | $7,078,277 | 2.68% |
| AlphaCentric Advisors LLC | 202,500 | $2,008,800 | 1.48% |
| Novo Holdings A/S | 2,500,000 | $24,800,000 | 1.44% |